Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
miRNAs: roles and clinical applications in vascular disease Jamaluddin MS; Weakley SM; Zhang L; Kougias P; Lin PH; Yao Q; Chen CExpert Rev Mol Diagn 2011[Jan]; 11 (1): 79-89miRNAs are small, endogenously expressed noncoding RNAs that regulate gene expression, mainly at the post-transcriptional level, via degradation or translational inhibition of their target mRNAs. Functionally, an individual miRNA can regulate the expression of multiple target genes. The study of miRNAs is rapidly growing and recent studies have revealed a significant role of miRNAs in vascular biology and disease. Many miRNAs are highly expressed in the vasculature, and their expression is dysregulated in diseased vessels. Several miRNAs have been found to be critical modulators of vascular pathologies, such as atherosclerosis, lipoprotein metabolism, inflammation, arterial remodeling, angiogenesis, smooth muscle cell regeneration, hypertension, apoptosis, neointimal hyperplasia and signal transduction pathways. Thus, miRNAs may serve as novel biomarkers and/or therapeutic targets for vascular disease. This article summarizes the current studies related to the disease correlations and functional roles of miRNAs in the vascular system and discusses the potential applications of miRNAs in vascular disease.|Aging/physiology[MESH]|Apoptosis/physiology[MESH]|Atherosclerosis/genetics/pathology/therapy[MESH]|Blood Vessels/metabolism/pathology/physiopathology[MESH]|Cardiovascular Diseases/*genetics/pathology/therapy[MESH]|Constriction, Pathologic/genetics/therapy[MESH]|Humans[MESH]|Hyperplasia[MESH]|Hypertension, Pulmonary/genetics/therapy[MESH]|MicroRNAs/*physiology[MESH]|Molecular Targeted Therapy[MESH]|Neointima/pathology[MESH]|Neovascularization, Pathologic/genetics[MESH]|Neovascularization, Physiologic[MESH]|Signal Transduction/physiology[MESH]|Stroke/genetics/therapy[MESH] |
